#VisualAbstract: Best endovascular treatment superior to vein bypass for patients with chronic limb ischemia requiring infrapopliteal revascularization

2. Cardiovascular and respiratory-related events contributed to most morbidity and mortality cases.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Chronic limb ischemia is the most severe form of peripheral arterial disease which often requires invasive interventions such as angioplasty, bypass grafting, and amputation. Despite successful revascularization, patients with chronic limb ischemia require multiple procedures and frequent hospital readmissions. This randomized controlled trial aimed to compare the safety and efficacy of vein bypass with the best endovascular treatment in patients with chronic limb-threatening ischemia. The primary outcome was amputation-free survival and death while key secondary outcomes included time to major amputation or revascularization. According to study results, best endovascular treatment was associated with better amputation-free survival compared to the vein bypass strategy. Although this study was well-done, it was largely skewed toward male patients who are known to have fewer complications of limb ischemia compared to female patients.

Click to read the study in The Lancet

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.